EGFR and hepatocellular carcinoma: (3) reported that HCC cell-derived S100A10-enriched EVs enhance the stemness and metastasis capacity of HCC cells, up-regulate EGFR, AKT, and ERK signaling, and promote epithelial-mesenchymal transformation (EMT).